Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 20 studies | 29% ± 11% | |
oligodendrocyte | 12 studies | 42% ± 16% | |
glutamatergic neuron | 11 studies | 43% ± 25% | |
fibroblast | 10 studies | 29% ± 11% | |
macrophage | 10 studies | 29% ± 13% | |
astrocyte | 10 studies | 39% ± 17% | |
adipocyte | 9 studies | 35% ± 8% | |
pericyte | 9 studies | 25% ± 14% | |
epithelial cell | 8 studies | 31% ± 16% | |
GABAergic neuron | 8 studies | 41% ± 23% | |
microglial cell | 8 studies | 31% ± 9% | |
oligodendrocyte precursor cell | 7 studies | 31% ± 11% | |
myeloid cell | 6 studies | 23% ± 6% | |
dendritic cell | 6 studies | 22% ± 3% | |
basal cell | 6 studies | 29% ± 17% | |
endothelial cell of lymphatic vessel | 6 studies | 33% ± 13% | |
smooth muscle cell | 6 studies | 24% ± 5% | |
neuron | 5 studies | 38% ± 18% | |
ciliated cell | 5 studies | 21% ± 5% | |
monocyte | 5 studies | 24% ± 5% | |
interneuron | 5 studies | 46% ± 25% | |
retinal ganglion cell | 4 studies | 27% ± 8% | |
cardiac muscle cell | 4 studies | 31% ± 5% | |
club cell | 4 studies | 30% ± 9% | |
type I pneumocyte | 4 studies | 27% ± 10% | |
type II pneumocyte | 4 studies | 25% ± 8% | |
hematopoietic precursor cell | 3 studies | 19% ± 2% | |
plasma cell | 3 studies | 32% ± 6% | |
mesothelial cell | 3 studies | 26% ± 7% | |
vein endothelial cell | 3 studies | 35% ± 20% | |
respiratory goblet cell | 3 studies | 27% ± 6% | |
abnormal cell | 3 studies | 26% ± 12% | |
connective tissue cell | 3 studies | 20% ± 2% | |
ependymal cell | 3 studies | 27% ± 15% | |
T cell | 3 studies | 17% ± 0% | |
alveolar macrophage | 3 studies | 38% ± 10% | |
lymphocyte | 3 studies | 26% ± 9% | |
goblet cell | 3 studies | 37% ± 29% | |
transit amplifying cell | 3 studies | 38% ± 26% | |
granule cell | 3 studies | 29% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 9450.25 | 459 / 459 | 100% | 75.41 | 1118 / 1118 |
esophagus | 100% | 8206.66 | 1445 / 1445 | 100% | 64.75 | 183 / 183 |
prostate | 100% | 9814.16 | 245 / 245 | 100% | 87.13 | 502 / 502 |
stomach | 100% | 7069.92 | 359 / 359 | 100% | 48.82 | 286 / 286 |
thymus | 100% | 8078.82 | 653 / 653 | 100% | 46.90 | 604 / 605 |
intestine | 100% | 8793.11 | 966 / 966 | 100% | 49.54 | 526 / 527 |
bladder | 100% | 9088.33 | 21 / 21 | 100% | 43.04 | 503 / 504 |
uterus | 100% | 9058.92 | 170 / 170 | 100% | 48.14 | 458 / 459 |
lung | 100% | 8500.47 | 577 / 578 | 100% | 46.56 | 1150 / 1155 |
pancreas | 99% | 5233.76 | 326 / 328 | 100% | 41.82 | 178 / 178 |
kidney | 100% | 6302.09 | 89 / 89 | 99% | 39.60 | 895 / 901 |
liver | 100% | 3985.68 | 225 / 226 | 100% | 29.11 | 404 / 406 |
brain | 100% | 7894.68 | 2631 / 2642 | 99% | 38.16 | 701 / 705 |
skin | 100% | 9194.42 | 1809 / 1809 | 99% | 47.06 | 467 / 472 |
adrenal gland | 100% | 8669.54 | 258 / 258 | 98% | 39.04 | 225 / 230 |
ovary | 100% | 8843.43 | 180 / 180 | 96% | 29.02 | 414 / 430 |
adipose | 100% | 10100.29 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 40.21 | 29 / 29 |
muscle | 100% | 39531.74 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5948.66 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 54.06 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 22.15 | 1 / 1 |
blood vessel | 100% | 8628.54 | 1334 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 49.16 | 78 / 80 |
heart | 97% | 6429.54 | 831 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 78% | 3989.71 | 722 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043248 | Biological process | proteasome assembly |
GO_0036503 | Biological process | ERAD pathway |
GO_0000502 | Cellular component | proteasome complex |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0030139 | Cellular component | endocytic vesicle |
GO_0016020 | Cellular component | membrane |
GO_0005769 | Cellular component | early endosome |
GO_0005813 | Cellular component | centrosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005770 | Cellular component | late endosome |
GO_0005793 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment |
GO_0005771 | Cellular component | multivesicular body |
GO_0030134 | Cellular component | COPII-coated ER to Golgi transport vesicle |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0070628 | Molecular function | proteasome binding |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ECPAS |
Protein name | Ecm29 proteasome adaptor and scaffold Proteasome adapter and scaffold protein ECM29 (Ecm29 proteasome adapter and scaffold) (Proteasome-associated protein ECM29 homolog) |
Synonyms | ECM29 KIAA0368 |
Description | FUNCTION: Adapter/scaffolding protein that binds to the 26S proteasome, motor proteins and other compartment specific proteins. May couple the proteasome to different compartments including endosome, endoplasmic reticulum and centrosome. May play a role in ERAD and other enhanced proteolysis . Promotes proteasome dissociation under oxidative stress (By similarity). . |
Accessions | J3KN16 Q5VYK3 ENST00000602978.1 R4GMY3 ENST00000602447.5 F6XAQ5 R4GMY1 ENST00000259335.8 ENST00000374383.1 ENST00000684092.1 [Q5VYK3-2] |